AI Summary Genetic and metabolic liver disease testing checks for inherited conditions that cause iron or copper buildup or an abnormal protein: hereditary hemochromatosis, Wilson disease, and alpha-1 antitrypsin deficiency. Doctors order it for unexplained abnormal liver enzymes, a family history, or symptoms like joint pain, fatigue, or neurological changes. Tests include iron studies and HFE gene testing, ceruloplasmin and 24-hour urine copper, and an AAT blood level with genetic testing. Early detection allows treatment before organ damage.
Source: www.liverdirectory.com
Medically Reviewed.
Genetic and metabolic liver disease testing looks for inherited conditions that cause the liver to store too much iron or copper, or to build up an abnormal protein. These conditions include hereditary hemochromatosis, Wilson disease, and alpha-1 antitrypsin deficiency (AATD). Because symptoms often develop slowly or not at all early on, blood tests, a 24-hour urine test, and genetic testing are usually how these conditions are first found.
Doctors order this group of tests when liver enzymes are abnormal with no clear cause, when a close relative has a genetic liver condition, or when routine screening flags unusual iron or protein levels. A positive result on one test often leads to a second, more specific test — for example, an abnormal iron panel is typically followed by HFE gene testing to confirm hereditary hemochromatosis.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
Iron, Copper, and Protein Tests
Genetic and metabolic liver disease testing covers three main conditions, each with its own set of tests. Explore each test in detail on its own page.
Hemochromatosis testing starts with an iron panel: transferrin saturation and serum ferritin. A transferrin saturation above 45% or a high ferritin level points to iron overload and usually leads to HFE gene testing, which checks for the C282Y and H63D mutations responsible for most cases of hereditary hemochromatosis.
Wilson disease testing looks for abnormal copper metabolism. A ceruloplasmin blood test measures the main copper-carrying protein, which is often low in Wilson disease. A 24-hour urine copper collection measures how much copper the body is excreting; a result above 100 mcg in a symptomatic, untreated patient supports the diagnosis. Genetic testing for ATP7B mutations can confirm the diagnosis, especially for screening family members.
Alpha-1 antitrypsin deficiency (AATD) testing measures the level of AAT protein in the blood. A low level suggests the condition, and genetic testing can confirm which SERPINA1 gene mutations a person carries. AATD is inherited, so this testing can also help family members understand their own risk.
Lab Values Explained
These reference ranges can vary by lab. Always review results with your doctor, who will interpret them alongside your symptoms and other tests.
| Test | Typical normal range | What an abnormal result may suggest |
|---|---|---|
| Transferrin saturation | 20% to 45% | Above 45% suggests iron overload and may prompt HFE gene testing for hereditary hemochromatosis |
| Serum ferritin | Roughly 20 to 250 ng/mL (varies by sex and lab) | Above 1,000 ng/mL, with elevated liver enzymes and low platelets, strongly predicts cirrhosis in hereditary hemochromatosis |
| Serum ceruloplasmin | Roughly 20 to 40 mg/dL | Low levels support a diagnosis of Wilson disease, though levels can be normal in about half of patients with active liver disease |
| 24-hour urine copper | Under 40 mcg per 24 hours | Above 100 mcg per 24 hours in an untreated, symptomatic patient is generally considered diagnostic for Wilson disease |
| Alpha-1 antitrypsin (AAT) level | Roughly 100 to 200 mg/dL | Low levels suggest AATD and are typically followed by genetic testing to identify the specific SERPINA1 mutation |
Reference ranges vary between laboratories. This table is for general education only and does not replace a discussion with your doctor.
When Testing Is Recommended
Doctors typically order genetic and metabolic liver disease testing in specific situations rather than as routine screening for everyone.
Unexplained abnormal liver enzymes are one of the most common reasons for this testing. When routine liver function tests come back abnormal and there is no clear cause such as alcohol use, viral hepatitis, or medication side effects, doctors often add iron studies, and sometimes ceruloplasmin or AAT levels, to look for an underlying genetic cause.
A family history of hereditary hemochromatosis, Wilson disease, or AATD raises the chance that a relative also carries the same gene mutation. First-degree relatives (parents, siblings, and children) of someone diagnosed with one of these conditions are often offered testing, even without symptoms, because early detection allows treatment to start before organ damage occurs.
Certain symptom patterns point doctors toward specific tests. Joint pain, fatigue, and skin darkening can suggest hemochromatosis. Neurological changes or unexplained liver disease in a younger person can suggest Wilson disease. Early-onset emphysema in a nonsmoker, or liver disease without another explanation, can suggest AATD.
Amsety Bars were designed for people with liver conditions by liver health experts. They offer a convenient way to add energy and nutrients to a liver-friendly diet. Ask your provider what fits your needs.
Explore Liver Health Nutrition Bars
Liver Health Coach
Liver health support
BetterLix is a digital liver health support app designed to help you understand liver conditions, track symptoms, and build healthier daily habits. It provides simple, personalized guidance to help you stay informed about your liver health and monitor progress over time.
Common Questions
Yes. Transferrin saturation and serum ferritin are usually the first tests, since they can be added to a routine blood draw. If either result is abnormal, your doctor will typically order HFE gene testing to check for the mutations linked to hereditary hemochromatosis.
A single low ceruloplasmin result does not confirm Wilson disease on its own — levels can be low-normal in about half of patients with active liver disease, and other conditions can also lower it. Doctors typically combine ceruloplasmin with a 24-hour urine copper test, and sometimes genetic testing for ATP7B mutations, before making a diagnosis.
AATD is inherited in an autosomal recessive pattern, meaning a person needs two copies of the mutated SERPINA1 gene (one from each parent) to develop the condition. People with only one copy are carriers and usually do not develop liver or lung disease from it, though they can pass the gene to their children.
Not necessarily. Many people with these genetic changes never develop significant organ damage. For example, fewer than 10% of people who are genetically susceptible to hereditary hemochromatosis go on to develop severe iron overload with organ damage. That said, an abnormal result should still be discussed with a doctor, who can advise on monitoring or further testing based on your individual case.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
